RSNA

In a recent interview at the RSNA conference, Roland Rott shared his perspective on the planned acquisition of Intelerad by GE HealthCare along with insights on key synergies and future directions.

In a recent interview at the RSNA conference, Manisha Bahl, M.D., discussed new research examining the use of slab reconstruction technology with digital breast tomosynthesis (DBT), and its potential in reducing interpretation time and imaging volume.

In a recent interview at the RSNA conference, Talissa Altes, M.D., and Konstanze Diefenbach, M.D., discussed the potential utility and recent research findings on the use of the MRI contrast agent gadoquatrane for pediatric patients.

For men with a 1 μg/m3 increase in ten-year exposure to fine particulate matter, a common air pollutant, there was a 47 increased likelihood of moving to a higher CAD-RADS stenosis category, according to new coronary CT angiography research presented at the Radiological Society of North America (RSNA) conference.

Absent flow to perforator vessels in the face occurred in over 40 percent of women who had cosmetic fillers, according to new vascular ultrasound research presented at the RSNA conference.

The Resona A20 device reportedly provides advances in imaging and AI automation along with an intuitive ergonomic design for ease of use.

In a recent interview at the RSNA conference, Constance Lehman, M.D., Ph.D., discussed new research, which compared image-based AI for mammography versus breast density assessment in evaluating breast cancer risk.

The addition of ClearCEM to Mammomat B.brilliant devices reportedly enhances differentiation of suspicious areas in image reconstruction and facilitates improved accuracy with tomosynthesis-guided biopsies.

In a recent interview, Stamatia Destounis, M.D., discussed new research, which showed that over 20 percent of breast cancer was detected in women under 50 years of age and that 80 percent of these cases involved invasive breast cancer.

Reportedly the first MRI platform with a helium-free 3T magnet, the BlueSeal Horizon device offers a variety of AI-powered features as well as enhanced 3D image reconstruction.

In a study of over 13,000 patients who presented with knee pain, MRI data demonstrated a 20 percent higher prevalence of anterior cruciate ligament (ACL) tears in men than women.

Deep learning assessment of adrenal gland volume on computed tomography (CT) scans may provide an objective assessment of chronic stress with significant links to adverse cardiovascular outcomes, according to new research to be presented at the Radiological Society of North America (RSNA) annual meeting.

Combining AI advances and ergonomic innovation, the R20 ultrasound platform reportedly offers a variety of automated tools and design features to facilitate a smoother, efficient imaging workflow.

In MRI findings to be presented at the upcoming RSNA meeting, researchers demonstrated that the combination of higher muscle mass and lower visceral fat may have an impact on brain aging.

Geared toward interventional radiologists, the Alphenix 4D CT with Aquilion One/Insight Edition combines angiography capabilities with advanced features in computed tomography.

The Synapse One platform reportedly offers a variety of enterprise imaging capabilities and may facilitate reduced third-party integration complexities and costs.

The latest update of the Cardiovascular Workspace software reportedly emphasizes secure cloud deployment and accelerated adoption of AI tools for increased efficiency.

In the third part of a three-part interview from the recent RSNA conference, Mark Traill, M.D., discusses the potential of image-based risk assessment artificial intelligence (AI) algorithms in bolstering adherence to screening protocols for women at high risk for breast cancer.

Catch up on emerging research from the recent 2024 Radiological Society of North America (RSNA) conference.

Catch up on video interviews from the recent 2024 Radiological Society of North America (RSNA) conference.

In the second part of a three-part interview from the recent RSNA conference, Mark Traill, M.D., emphasizes patience and monitoring with the assessment of AI to ensure optimal use of the technology to help ease the strain of increasing breast imaging volume.

In the first of a three-part interview from the recent RSNA conference, Mark Traill, M.D., discusses current challenges in breast radiology and the potential of AI to help mitigate some of these issues.

In a recent interview at the RSNA conference, Raj Chopra, MD shared his insights on the continued rise of cyberattacks, the impact of these attacks in radiology and keys to prevention and effectively responding to such events.

In an interview at the RSNA conference, Sundus Lateef, MD, discussed the rise of silicosis and associated CT findings in a recent study of engineered stone countertop workers.

In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.

Emerging research from the RSNA conference suggests that two-dimensional mammography would only detect 41 percent of detectable breast cancer.

In a recent interview, Sarah Friedewald, MD, discussed new study findings for an adjunctive AI software for digital breast tomosynthesis (DBT) that revealed nearly equivalent sensitivity and specificity rates for breast cancer across a diverse cohort.

In a multicenter study involving over 747,000 women who had mammography screening, those who paid for AI-enhanced screening had a 21 percent higher recall rate and a 15 percent higher positive predictive value (PPV) for breast cancer, according to research presented at the Radiological Society of North America (RSNA) conference.

In a recent interview at the RSNA conference, Shadpour Demehri, MD and Kamyar Moradi, MD discussed new brain MRI research findings that demonstrated a link between increased dementia risk and sarcopenia with the temporalis muscle.

The computed tomography device reportedly offers enhanced post-processing of images as well as bolstered image reconstruction capabilities with an 80 percent reduction in radiation dosing.